Teleflex Incorporated (TFX)

Check out top investors' recommendation for TFX
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
350.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures worldwide. It offers vascular access products for use in various clinical procedures to facilitate critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; anesthesia products, such as airway and pain management products under the Rusch brand name; respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand name; and urology products for patients in hospital and home care markets. The company also offers surgical products, which include ligation and closure products used in surgical procedures; access ports for use in minimally invasive surgical procedures; fluid management products for use in chest drainage; and reusable hand-held instruments under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brand names for general and specialty surgical procedures. In addition, it offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters, angiographic catheters, sheaths for femoral and trans-radial aortic access, and intra-aortic balloon catheters; and capital equipment, such as intra-aortic balloon pumps. Further, the company offers OEM products, including custom-manufactured extrusions, catheters, introducers, dilators, and other devices under the TFX OEM brand name, as well as markets specialty sutures, resins, and yarns for cardiovascular and orthopedic applications under the Deknatel brand name. Teleflex Incorporated offers its products to hospitals and healthcare providers in approximately 140 countries through its direct sales force and distributors. The company was founded in 1943 and is headquartered in Limerick, Pennsylvania.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Lawrence Keusch Raymond James Buy   Jun 20, '19     350.00  Jun 20, '20  N/A 
Michael Matson Mizuho Securities USA Buy   Mar 26, '19     325.00  Mar 26, '20  N/A 
Matthew Taylor National Bank Financial Buy   Mar 22, '19     350.00  Mar 22, '20  N/A 
David Lewis Morgan Stanley Buy   Feb 26, '19     315.00  Feb 26, '20  N/A 
Michael Matson Mizuho Securities USA Buy   Feb 22, '19     325.00  Feb 22, '20  N/A 
Chris Cooley Stephens Inc. Buy   Feb 21, '19     300.00  Feb 21, '20  N/A 
David Lewis Morgan Stanley Buy   Jan 02, '19     305.00  Jan 02, '20  N/A 
Michael Matson Mizuho Securities USA Buy   Sep 10, '18     300.00  Sep 10, '19  N/A 
Michael Matson Mizuho Securities USA Buy   Aug 03, '18     279.00  Aug 03, '19  N/A 
Raj Denhoy Jefferies & Co. Buy   Aug 03, '18     285.00  Aug 03, '19  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   Aug 02, '18     295.00  Aug 02, '19  N/A 
Raj Denhoy Jefferies & Co. Buy   Jun 22, '18     305.00  Jun 22, '19  N/A 
Richard Newitter Leerink Swann Llc Buy   Jun 05, '18     317.00  Jun 05, '19  N/A 
Michael Matson Mizuho Securities USA Buy   Mar 27, '18     285.00  Mar 27, '19  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   Mar 02, '18     295.00  Mar 02, '19  N/A 
Michael Matson Mizuho Securities USA Buy   Feb 23, '18     285.00  Feb 23, '19  N/A 
Richard Newitter Leerink Swann Llc Buy   Jan 30, '18     321.00  Jan 30, '19  N/A 
Chris Cooley Stephens Inc. Buy   Jan 17, '18     300.00  Jan 17, '19  N/A 
Lawrence Keusch Raymond James Buy   Dec 18, '17     300.00  Dec 18, '18  N/A 
Michael Matson Mizuho Securities USA Buy   Dec 05, '17     285.00  Dec 05, '18  N/A 
< previous123